Global Cell Line Development Market: 8-10% CAGR Growth and Biopharmaceutical Innovation by 2029
The cell line development market is growing at a CAGR of approximately 8-10% due to the increasing adoption of cell-based therapies. Key drivers include the rising demand for monoclonal antibodies, advances in bioprocessing technologies, growing focus on personalized medicine, and increased R&D investments in biopharmaceuticals. However, challenges such as high costs, lengthy development timelines, and regulatory […]
Continue Reading